Atara Biotherapeutics, Inc. (ATRA)
NASDAQ · Healthcare
Atara Biotherapeutics, Inc. annual/quarterly total liabilities history from 2022 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Atara Biotherapeutics, Inc. total liabilities for the quarter ending December 31, 2025 were 58.7M, a 71.54% decrease year-over-year.
- Atara Biotherapeutics, Inc. total liabilities for 2025 were 58.7M, a 71.54% decrease from 2024.
- Atara Biotherapeutics, Inc. total liabilities for 2024 were 206.4M, a 22.04% decrease from 2023.
- Atara Biotherapeutics, Inc. total liabilities for 2023 were 264.7M, a 5.99% increase from 2022.
- Atara Biotherapeutics, Inc. total liabilities for 2022 were 249.8M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Atara Biotherapeutics, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $59 |
| 2024 | $206 |
| 2023 | $265 |
| 2022 | $250 |
| Atara Biotherapeutics, Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $59 |
| 2024-12-31 | $206 |
| 2023-12-31 | $265 |
| 2022-12-31 | $250 |
Atara Biotherapeutics, Inc. Total Liabilities — FAQ
Atara Biotherapeutics, Inc. (ATRA) total liabilities over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ATRA's total liabilities history?
The chart and table above show Atara Biotherapeutics, Inc.'s total liabilities by year and by quarter, including the growth rate.